Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
012/2023
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2022/1480 frá 7. september 2022 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin 2-fenýlfenól (þ.m.t. sölt þess, s.s. natríumsalt), 8-hýdroxýkínólín, amíðósúlfúrón, bensúlfúrón, bífenox, klórmekvat, klórótólúrón, klófentesín, klómasón, damínósíð, deltametrín, díkamba, dífenókónasól, díflúfeníkan, dímetaklór, esfenvalerat, etófenprox, fenoxapróp-P, fenprópidín, fenpýrasamín, flúdíoxóníl, flúfenaset, flúmetralín, fosþíasat, lenasíl, MCPA, MCPB, níkósúlfúrón, paraffínolíur, paraffínolíu, penkónasól, píklóram, próhexadíón, própakvisafóp, prósúlfókarb, kvisalófóp-P-etýl, kvisalófóp-P-tefúrýl, natríum-5-nítrógvæjakólat, natríum-o-nítrófenólat, natríum-p-nítrófenólat, brennistein, tebúfenpýrað, tetrakónasól, tríallat, tríflúsúlfúrón og trítósúlfúrón
Durchführungsverordnung (EU) 2022/1480 der Kommission vom 7. September 2022 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigungen für die Wirkstoffe 2-Phenylphenol (einschließlich seiner Salze, z. B. Natriumsalz), 8-Hydroxychinolin, Amidosulfuron, Bensulfuron, Bifenox, Chlormequat, Chlortoluron, Clofentezin, Clomazon, Daminozid, Deltamethrin, Dicamba, Difenoconazol, Diflufenican, Dimethachlor, Esfenvalerat, Etofenprox, Fenoxaprop-P, Fenpropidin, Fenpyrazamin, Fludioxonil, Flufenacet, Flumetralin, Fosthiazat, Lenacil, MCPA, MCPB, Nicosulfuron, Paraffinöle, Paraffinöl, Penconazol, Picloram, Prohexadion, Propaquizafop, Prosulfocarb, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Natrium-5-nitroguaiacolat, Natrium-o-nitrophenolat, Natrium-p-nitrophenolat, Schwefel, Tebufenpyrad, Tetraconazol, Triallat, Triflusulfuron und Tritosulfuron
Kommisjonens gjennomføringsforordning (EU) 2022/1480 av 7. september 2022 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperiodene for de aktive stoffene 2-fenylfenol (herunder saltene, for eksempel natriumsalt), 8-hydroksykinolin, amidosulfuron, bensulfuron, bifenoks, klormekvat, klortoluron, klofentezin, klomazon, daminozid, deltametrin, dikamba, difenokonazol, diflufenikan, dimetaklor, esfenvalerat, etofenproks, fenoksaprop-P, fenpropidin, fenpyrazamin, fludioksonil, flufenacet, flumetralin, fostiazat, lenacil, MCPA, MCPB, nikosulfuron, parafinoljer, parafinolje, penkonazol, pikloram, proheksadion, propakizafop, prosulfokarb, kizalofop-P-etyl, kizalofop-P-tefuryl, natrium-5-nitroguaiakolat, natrium-o-nitrofenolat, natrium-p-nitrofenolat, svovel, tebufenpyrad, tetrakonazol, tri-allat, triflusulfuron og tritosulfuron
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.